Results 61 to 70 of about 13,189,470 (203)
Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice [PDF]
, 2011 Nan Xu1,2, Julin Gu3, Yuanjie Zhu3, Hai Wen3, Qiushi Ren1, Jianghan Chen31Institute for Laser Medicine and Biophotonics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China; 2Department ...
Wen H +11 more
core +1 more source
Nippon Ishinkin Gakkai Zasshi, 2005 Liposomal amphotericin B (AmBisome) is a DDS (drug delivery system) formulation of amphotericin B (AMPH-B), and has been developed in an attempt to reduce the toxicity of AMPH-B while retaining its therapeutic efficacy. AMPH-B has been the "gold standard" of antifungal therapy over the past four decades.
openaire +3 more sources
Antibiotics and antifungals in silicone oil
International Journal of Retina and Vitreous, 2019 Background Antimicrobials may be injected into silicone oil-filled eyes with endophthalmitis, but the interaction with oil is unclear. The purpose of the experiment is to determine whether vancomycin, amikacin, and amphotericin B mix with silicone oil ...
Ella H. Leung, J. Timothy Stout
doaj +1 more source
The Inhibitory Effect of Validamycin A on Aspergillus flavus
International Journal of Microbiology, 2020 Aspergillus flavus is one of the most common isolates from patients with fungal infections. Aspergillus infection is usually treated with antifungal agents, but side effects of these agents are common.
Napasawan Plabutong +6 more
doaj +1 more source
In situ Gelling Amphotericin B Nanofibers: A New Option for the Treatment of Keratomycosis
Frontiers in Bioengineering and Biotechnology, 2020 The purpose of our research was the development of Amphotericin B-loaded in situ gelling nanofibers for the treatment of keratomycosis. Different formulation strategies were applied to increase the drug load of the sparingly water-soluble Amphotericin B ...
Benedikt Göttel +7 more
doaj +1 more source
, 2008 PH ChandrasekarDivision of Infectious Diseases, Department of Internal Medicine, Wayne State University, Karmanos Cancer Institute, Detroit, MI, USAAbstract: Amphotericin B lipid complex (ABLC) was introduced in the late 1990s as a less toxic alternative
PH Chandrasekar
core
MicroorganismsBackground: Invasive mucormycosis (IM) poses a substantial morbidity and mortality burden among immunocompromised patients. Objectives: We aim to compare the real-world effectiveness and safety of isavuconazole with those of amphotericin B in patients ...
Jiayuan Qin +6 more
doaj +1 more source
Antifungal Activity of Silver Nanoparticles, Copper Nanoparticles, Their Combination and with Amphotericin B against Candida glabrata In vitro and In vivo [PDF]
Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2017 Background: Candida glabrata is the fourth most common cause of blood infection in America and, due to its resistance to amphotericin B, we have to look for new therapies.
Mahdi Jafarzadeh +2 more
doaj
Leishmaniasis cutánea y anfotericina B liposomal: Reporte de caso
InfectioLa leishmaniasis cutánea es una zoonosis producida por diferentes especies del parásito del género Leishmania . Existen 2 tipos de leishmaniasis, la que se conoce como del nuevo mundo y la del viejo mundo, que son causadas por diferentes especies.
Juan Diego Vélez L +1 more
doaj
Indian Journal of TransplantationLiposomal amphotericin B is a macrolide polyene antibiotic which is used to treat serious fungal infections. The common adverse effects of liposomal amphotericin B include nephrotoxicity, hypokalemia, hypomagnesemia, anemia, and anaphylaxis. We present a
U. Kaviya +4 more
doaj +1 more source